XML 65 R54.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SEGMENTS (Details)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
USD ($)
Facility
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
Segment
Jun. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Segment Reporting Information [Abstract]          
Number of FDA-licensed plasma collection facilities | Facility 10        
Number of operating segments | Segment     2    
Revenues $ 107,191 $ 60,123 $ 189,066 $ 117,037  
Cost of product revenue 49,738 43,433 92,505 83,834  
Income (loss) from operations 39,201 (473) 61,022 (1,286)  
Interest and other (expense) income, net (3,350) (5,898) (6,770) (11,874)  
INCOME (LOSS) BEFORE INCOME TAXES 35,851 (6,371) 54,252 (13,160)  
Capital expenditures     4,413 2,817  
Depreciation and amortization expense 2,047 2,098 4,161 4,131  
Total assets 376,399 343,027 376,399 343,027 $ 329,182
United States [Member]          
Segment Reporting Information [Abstract]          
Revenues 102,726 56,608 180,717 109,303  
International [Member]          
Segment Reporting Information [Abstract]          
Revenues 4,465 3,515 8,349 7,734  
Corporate [Member]          
Segment Reporting Information [Abstract]          
Revenues 36 36 71 71  
Cost of product revenue 0 0 0 0  
Income (loss) from operations (6,274) (5,157) (12,095) (10,501)  
Interest and other (expense) income, net (3,337) (5,893) (6,725) (11,844)  
INCOME (LOSS) BEFORE INCOME TAXES (9,611) (11,050) (18,820) (22,345)  
Capital expenditures     0 0  
Depreciation and amortization expense 0 0 0 0  
Total assets 84,697 57,405 84,697 57,405  
Operating Segments [Member] | ADMA BioManufacturing [Member]          
Segment Reporting Information [Abstract]          
Revenues 106,183 59,761 186,297 109,339  
Cost of product revenue 48,471 43,041 89,462 76,975  
Income (loss) from operations 46,712 6,084 75,409 11,561  
Interest and other (expense) income, net (10) (6) (41) (30)  
INCOME (LOSS) BEFORE INCOME TAXES 46,702 6,078 75,368 11,531  
Capital expenditures     4,338 1,195  
Depreciation and amortization expense 1,241 1,283 2,548 2,575  
Total assets 258,095 248,163 258,095 248,163  
Operating Segments [Member] | Plasma Collection Centers [Member]          
Segment Reporting Information [Abstract]          
Revenues 972 326 2,698 7,627  
Cost of product revenue 1,267 392 3,043 6,859  
Income (loss) from operations (1,237) (1,400) (2,292) (2,346)  
Interest and other (expense) income, net (3) 1 (4) 0  
INCOME (LOSS) BEFORE INCOME TAXES (1,240) (1,399) (2,296) (2,346)  
Capital expenditures     75 1,622  
Depreciation and amortization expense 806 815 1,613 1,556  
Total assets $ 33,607 $ 37,459 $ 33,607 $ 37,459